After almost 20 years in business, Algorithme Pharma conducts over 200 clinical trials annually in Phase I/IIa, Bioequivalence and Bioanalysis (preclinical to Phase I-IV) with the participation of over 5,000 participants. Our clients are based throughout the world. Today, our team is made up of close to 500 professionals from the medical and scientific fields who work together to achieve a common goal: to contribute to the advancement of pharmaceutical science. Our goal is to provide the best quality early stage clinical development services to an international customer base of generic, biotechnology and pharmaceutical companies with a focus on customer service. We will achieve this by continuously looking for ways to improve our customer relationships and range of services and by creating an environment that provides value for our customers, respect for our participants, returns for our shareholders and growth for our employees.
Algorithme Pharma, a member of Altasciences, is an early stage clinical CRO with a full service offering, from study design to study conduct, PK analysis and bioanalysis. We have been servicing international pharmaceutical, biotechnology and generic drug companies for over 20 years.
The team, of almost 500 professionals from the medical and scientific fields, work together to conduct Phase I/IIa, 505(b)(2) and Bioequivalence clinical trials, involving over 5,000 participants including patient populations. Good Laboratory Practice, and Good Clinical Practice quality systems are applied to all aspects of our services.Our GLP-compliant bioanalytical facilities perform large and small molecule bioanalysis on samples from preclinical to Phase IV studies.
Our clients are based throughout the world with the majority being split between Europe and North America giving us many years of experience in preparing submissions for these key regulatory authorities. Benefitting from a focused and thorough approach to quality, we are proud to have a long and successful inspection and audit history, including the following agencies: FDA (USA), TPD (Canada), ANSM (France), ANVISA (Brazil), MHRA (United Kingdom), AGES (Austria), AEMPS (Spain).
575, Armand-Frappier Blvd.
Canada H7V 4B3
Algorithme Pharma - http://www.algopharm.com